_id
69109752ccc777a4e85d5bb1
Ticker
ENSC
Name
Ensysce Biosciences Inc
Exchange
NASDAQ
Address
7946 Ivanhoe Avenue, La Jolla, CA, United States, 92037
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.ensysce.com
Description
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company's lead product candidate is PF614, a TAAP oxycodone prodrug candidate for the treatment of severe or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection. It is also developing PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for attention deficit hyperactivity disorder; and PF9001 to treat Opioid use disorder.Ensysce Biosciences, Inc. was founded in 2003 and is based in La Jolla, California.
Last Close
0.92
Volume
52168
Current Price
1.04
Change
0.02
Last Updated
2026-01-03T11:02:32.947Z
Image
data:image/webp;base64,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
Ipo Date
2018-02-26T00:00:00.000Z
Market Cap
3414363
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.992
Sentiment Sources
1
Rating
4
Target Price
19.225
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
493104
Cost Of Revenue
2954909
Gross Profit
-2461805
Operating Expenses
1279290
Operating Income
-3741095
Interest Expense
6369
Pretax Income
-3729128
Net Income
-3729128
Eps
-1.2921177287089418
Dividends Per Share
-
Shares Outstanding
3632301
Income Tax Expense
-
EBITDA
18336
Operating Margin
-758.6827525227944
Total Other Income Expense Net
11967
Cash
1673218
Short Term Investments
-
Receivables
4411
Inventories
-
Total Current Assets
2928270
Property Plant Equipment
123643
Total Assets
3179464
Payables
463458
Short Term Debt
364066
Long Term Debt
0
Total Liabilities
2304750
Equity
1203363
Bs_currency_symbol
USD
Depreciation
3741095
Change In Working Capital
2343585
Cash From Operations
-1866179
Capital Expenditures
123643
Cash From Investing
-123643
Cash From Financing
1451465
Net Change In Cash
-538357
Cf_currency_symbol
USD
PE
-
PB
2.4942609669733904
ROE
-309.89219379356024
ROA
-117.28794538953736
FCF
-1989822
Fcf Percent
-4.035298841623674
Piotroski FScore
1
Health Score
25
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
1.5
Quality Investing Score
1.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
493104
Quarters > 0 > income Statement > cost Of Revenue
2954909
Quarters > 0 > income Statement > gross Profit
-2461805
Quarters > 0 > income Statement > operating Expenses
1279290
Quarters > 0 > income Statement > operating Income
-3741095
Quarters > 0 > income Statement > interest Expense
6369
Quarters > 0 > income Statement > pretax Income
-3729128
Quarters > 0 > income Statement > net Income
-3729128
Quarters > 0 > income Statement > eps
-1.2921177287089418
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2886059
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
18336
Quarters > 0 > income Statement > operating Margin
-758.6827525227944
Quarters > 0 > income Statement > total Other Income Expense Net
11967
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1673218
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
4411
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2928270
Quarters > 0 > balance Sheet > property Plant Equipment
123643
Quarters > 0 > balance Sheet > total Assets
3179464
Quarters > 0 > balance Sheet > payables
463458
Quarters > 0 > balance Sheet > short Term Debt
364066
Quarters > 0 > balance Sheet > long Term Debt
0
Quarters > 0 > balance Sheet > total Liabilities
2304750
Quarters > 0 > balance Sheet > equity
1203363
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3729128
Quarters > 0 > cash Flow > depreciation
3741095
Quarters > 0 > cash Flow > change In Working Capital
2343585
Quarters > 0 > cash Flow > cash From Operations
-1866179
Quarters > 0 > cash Flow > capital Expenditures
123643
Quarters > 0 > cash Flow > cash From Investing
-123643
Quarters > 0 > cash Flow > cash From Financing
1451465
Quarters > 0 > cash Flow > net Change In Cash
-538357
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.2921177287089418
Quarters > 0 > ratios > PB
2.4942609669733904
Quarters > 0 > ratios > ROE
-309.89219379356024
Quarters > 0 > ratios > ROA
-117.28794538953736
Quarters > 0 > ratios > FCF
-1989822
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-4.035298841623674
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1371438
Quarters > 1 > income Statement > cost Of Revenue
1923430
Quarters > 1 > income Statement > gross Profit
-551992
Quarters > 1 > income Statement > operating Expenses
1198523
Quarters > 1 > income Statement > operating Income
-1750515
Quarters > 1 > income Statement > interest Expense
3160
Quarters > 1 > income Statement > pretax Income
-1733517
Quarters > 1 > income Statement > net Income
-1733351
Quarters > 1 > income Statement > eps
-0.7870643359507496
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
2202299
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1730358
Quarters > 1 > income Statement > operating Margin
-127.64084121921661
Quarters > 1 > income Statement > total Other Income Expense Net
16998
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2211575
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1204979
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
5281595
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
5574455
Quarters > 1 > balance Sheet > payables
1042832
Quarters > 1 > balance Sheet > short Term Debt
424521
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
2514043
Quarters > 1 > balance Sheet > equity
3389061
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1733517
Quarters > 1 > cash Flow > depreciation
1750515
Quarters > 1 > cash Flow > change In Working Capital
-1224923
Quarters > 1 > cash Flow > cash From Operations
-2706868
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
1865952
Quarters > 1 > cash Flow > net Change In Cash
-840916
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.7870643359507496
Quarters > 1 > ratios > PB
0.6758187474347614
Quarters > 1 > ratios > ROE
-51.14546477623153
Quarters > 1 > ratios > ROA
-31.094537492902894
Quarters > 1 > ratios > FCF
-2706868
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-1.97374434717428
Quarters > 1 > health Score
29
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1320000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
1320000
Quarters > 2 > income Statement > operating Expenses
3287284
Quarters > 2 > income Statement > operating Income
-1968000
Quarters > 2 > income Statement > interest Expense
3856
Quarters > 2 > income Statement > pretax Income
-1946000
Quarters > 2 > income Statement > net Income
-1946000
Quarters > 2 > income Statement > eps
-1.389007851534618
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1401000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1942000
Quarters > 2 > income Statement > operating Margin
-149.0909090909091
Quarters > 2 > income Statement > total Other Income Expense Net
21939
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3052491
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
22000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
4400991
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
4611874
Quarters > 2 > balance Sheet > payables
615295
Quarters > 2 > balance Sheet > short Term Debt
257383
Quarters > 2 > balance Sheet > long Term Debt
0
Quarters > 2 > balance Sheet > total Liabilities
1891356
Quarters > 2 > balance Sheet > equity
3049000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1945573
Quarters > 2 > cash Flow > depreciation
1968000
Quarters > 2 > cash Flow > change In Working Capital
182786
Quarters > 2 > cash Flow > cash From Operations
-1707412
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
1257826
Quarters > 2 > cash Flow > net Change In Cash
-449586
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.389007851534618
Quarters > 2 > ratios > PB
0.4778747130206625
Quarters > 2 > ratios > ROE
-63.82420465726467
Quarters > 2 > ratios > ROA
-42.195428582827724
Quarters > 2 > ratios > FCF
-1707412
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.2934939393939393
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1303659
Quarters > 3 > income Statement > cost Of Revenue
3802630
Quarters > 3 > income Statement > gross Profit
-2498971
Quarters > 3 > income Statement > operating Expenses
1077505
Quarters > 3 > income Statement > operating Income
-3576476
Quarters > 3 > income Statement > interest Expense
10753
Quarters > 3 > income Statement > pretax Income
-3564422
Quarters > 3 > income Statement > net Income
-3564422
Quarters > 3 > income Statement > eps
-2.9002620016273393
Quarters > 3 > income Statement > dividends Per Share
289999710
Quarters > 3 > income Statement > shares Outstanding
1229000
Quarters > 3 > income Statement > income Tax Expense
74
Quarters > 3 > income Statement > EBITDA
-3554000
Quarters > 3 > income Statement > operating Margin
-274.34137301242123
Quarters > 3 > income Statement > total Other Income Expense Net
12054
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3502077
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
124115
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5344682
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
5597232
Quarters > 3 > balance Sheet > payables
1357079
Quarters > 3 > balance Sheet > short Term Debt
301660
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
2217293
Quarters > 3 > balance Sheet > equity
3708422
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-3564422
Quarters > 3 > cash Flow > depreciation
1197198828535
Quarters > 3 > cash Flow > change In Working Capital
2752548
Quarters > 3 > cash Flow > cash From Operations
-764090
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
112575
Quarters > 3 > cash Flow > net Change In Cash
-651514
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-2.9002620016273393
Quarters > 3 > ratios > PB
0.34466411859275997
Quarters > 3 > ratios > ROE
-96.11694677682313
Quarters > 3 > ratios > ROA
-63.6818698956913
Quarters > 3 > ratios > FCF
-764090
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.5861118590060744
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
5210000
Annuals > 0 > income Statement > cost Of Revenue
7219000
Annuals > 0 > income Statement > gross Profit
-2009405
Annuals > 0 > income Statement > operating Expenses
4721000
Annuals > 0 > income Statement > operating Income
-6730000
Annuals > 0 > income Statement > interest Expense
1290000
Annuals > 0 > income Statement > pretax Income
-7987000
Annuals > 0 > income Statement > net Income
-7987000
Annuals > 0 > income Statement > eps
-4.571837435603892
Annuals > 0 > income Statement > dividends Per Share
290000000
Annuals > 0 > income Statement > shares Outstanding
1747000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-6729996
Annuals > 0 > income Statement > operating Margin
-129.17466410748563
Annuals > 0 > income Statement > total Other Income Expense Net
-1257000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
3502077
Annuals > 0 > balance Sheet > short Term Investments
3502073497923
Annuals > 0 > balance Sheet > receivables
124115
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5344682
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
5597232
Annuals > 0 > balance Sheet > payables
1357079
Annuals > 0 > balance Sheet > short Term Debt
301660
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2217293
Annuals > 0 > balance Sheet > equity
3708422
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-7987009
Annuals > 0 > cash Flow > depreciation
1197200000000
Annuals > 0 > cash Flow > change In Working Capital
-851249
Annuals > 0 > cash Flow > cash From Operations
-7502700000000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
9881173000000
Annuals > 0 > cash Flow > net Change In Cash
2378473000000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-4.571837435603892
Annuals > 0 > ratios > PB
0.4428244681969851
Annuals > 0 > ratios > ROE
-215.3746256494002
Annuals > 0 > ratios > ROA
-142.6955323631395
Annuals > 0 > ratios > FCF
-7502700000000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1440057.5815738963
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2231000
Annuals > 1 > income Statement > cost Of Revenue
7587000
Annuals > 1 > income Statement > gross Profit
-5357000
Annuals > 1 > income Statement > operating Expenses
5361000
Annuals > 1 > income Statement > operating Income
-10718000
Annuals > 1 > income Statement > interest Expense
353945
Annuals > 1 > income Statement > pretax Income
-10626000
Annuals > 1 > income Statement > net Income
-10613000
Annuals > 1 > income Statement > eps
-4.687720848056537
Annuals > 1 > income Statement > dividends Per Share
12937
Annuals > 1 > income Statement > shares Outstanding
2264000
Annuals > 1 > income Statement > income Tax Expense
-264
Annuals > 1 > income Statement > EBITDA
-10718000
Annuals > 1 > income Statement > operating Margin
-480.4123711340206
Annuals > 1 > income Statement > total Other Income Expense Net
91912
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1123604
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
97561
Annuals > 1 > balance Sheet > inventories
-535474
Annuals > 1 > balance Sheet > total Current Assets
2288868
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
2708085
Annuals > 1 > balance Sheet > payables
1936007
Annuals > 1 > balance Sheet > short Term Debt
854697
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3359352
Annuals > 1 > balance Sheet > equity
-322858
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-10626275
Annuals > 1 > cash Flow > depreciation
326151
Annuals > 1 > cash Flow > change In Working Capital
-947079
Annuals > 1 > cash Flow > cash From Operations
-10779982
Annuals > 1 > cash Flow > capital Expenditures
2
Annuals > 1 > cash Flow > cash From Investing
0
Annuals > 1 > cash Flow > cash From Financing
8755884
Annuals > 1 > cash Flow > net Change In Cash
-2024098
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-4.687720848056537
Annuals > 1 > ratios > PB
-6.5916285178003955
Annuals > 1 > ratios > ROE
3287.2036622911623
Annuals > 1 > ratios > ROA
-391.9005496503987
Annuals > 1 > ratios > FCF
-10779984
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-4.831906768265352
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2523380
Annuals > 2 > income Statement > cost Of Revenue
19835875
Annuals > 2 > income Statement > gross Profit
-17312492
Annuals > 2 > income Statement > operating Expenses
24222095
Annuals > 2 > income Statement > operating Income
-24222095
Annuals > 2 > income Statement > interest Expense
109525
Annuals > 2 > income Statement > pretax Income
-24207685
Annuals > 2 > income Statement > net Income
-24961561
Annuals > 2 > income Statement > eps
-138.72774714892293
Annuals > 2 > income Statement > dividends Per Share
913204
Annuals > 2 > income Statement > shares Outstanding
179932
Annuals > 2 > income Statement > income Tax Expense
753876
Annuals > 2 > income Statement > EBITDA
-24222095
Annuals > 2 > income Statement > operating Margin
-959.9067520547837
Annuals > 2 > income Statement > total Other Income Expense Net
14410
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
3147702
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
276821
Annuals > 2 > balance Sheet > inventories
-276821
Annuals > 2 > balance Sheet > total Current Assets
5299169
Annuals > 2 > balance Sheet > property Plant Equipment
27165
Annuals > 2 > balance Sheet > total Assets
5885052
Annuals > 2 > balance Sheet > payables
2943791
Annuals > 2 > balance Sheet > short Term Debt
4266610
Annuals > 2 > balance Sheet > long Term Debt
140150
Annuals > 2 > balance Sheet > total Liabilities
9914704
Annuals > 2 > balance Sheet > equity
-4029652
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-24207685
Annuals > 2 > cash Flow > depreciation
0
Annuals > 2 > cash Flow > change In Working Capital
5481820
Annuals > 2 > cash Flow > cash From Operations
-17887439
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
4500
Annuals > 2 > cash Flow > cash From Financing
8765905
Annuals > 2 > cash Flow > net Change In Cash
-9117034
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-138.72774714892293
Annuals > 2 > ratios > PB
-0.041972875077053794
Annuals > 2 > ratios > ROE
619.4470639151967
Annuals > 2 > ratios > ROA
-424.1519191334248
Annuals > 2 > ratios > FCF
-17887439
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-7.088682243657317
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3531200
Annuals > 3 > income Statement > cost Of Revenue
151
Annuals > 3 > income Statement > gross Profit
3531048
Annuals > 3 > income Statement > operating Expenses
19870431
Annuals > 3 > income Statement > operating Income
-19870431
Annuals > 3 > income Statement > interest Expense
1295307
Annuals > 3 > income Statement > pretax Income
-29145901
Annuals > 3 > income Statement > net Income
-29145750
Annuals > 3 > income Statement > eps
-346.89887881168323
Annuals > 3 > income Statement > dividends Per Share
803140000000
Annuals > 3 > income Statement > shares Outstanding
84018
Annuals > 3 > income Statement > income Tax Expense
-151
Annuals > 3 > income Statement > EBITDA
-19870280
Annuals > 3 > income Statement > operating Margin
-562.7104383778885
Annuals > 3 > income Statement > total Other Income Expense Net
-9275470
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
12264736
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
441721
Annuals > 3 > balance Sheet > inventories
-441721
Annuals > 3 > balance Sheet > total Current Assets
15662593
Annuals > 3 > balance Sheet > property Plant Equipment
24721000000
Annuals > 3 > balance Sheet > total Assets
16417349
Annuals > 3 > balance Sheet > payables
301104
Annuals > 3 > balance Sheet > short Term Debt
12748155
Annuals > 3 > balance Sheet > long Term Debt
4440951
Annuals > 3 > balance Sheet > total Liabilities
24575407
Annuals > 3 > balance Sheet > equity
-8158058
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-29145901
Annuals > 3 > cash Flow > depreciation
151
Annuals > 3 > cash Flow > change In Working Capital
-1303492
Annuals > 3 > cash Flow > cash From Operations
-8242177
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
20312699
Annuals > 3 > cash Flow > net Change In Cash
12070522
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-346.89887881168323
Annuals > 3 > ratios > PB
-0.009680848064576152
Annuals > 3 > ratios > ROE
357.26333399443837
Annuals > 3 > ratios > ROA
-177.53018468450662
Annuals > 3 > ratios > FCF
-8242177
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-2.3341008722247394
Annuals > 3 > health Score
31
Valuation > metrics > PE
-1.2921177287089418
Valuation > metrics > PB
2.4942609669733904
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-309.89219379356024
Profitability > metrics > ROA
-127.34918569667416
Profitability > metrics > Net Margin
-7.562558811123009
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.9152574908818036
Risk > metrics > Interest Coverage
-587.3912702151044
Risk > final Score
-2320
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.538592234182936
Liquidity > metrics > Quick Ratio
3.538592234182936
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-2168
Prev Risks > 1
-1993
Prev Risks > 2
-1282
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:46:54.752Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.29
Earnings History > 0 > eps Estimate
-0.93
Earnings History > 0 > eps Difference
-0.36
Earnings History > 0 > surprise Percent
-38.7097
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.79
Earnings History > 1 > eps Estimate
-1.09
Earnings History > 1 > eps Difference
0.3
Earnings History > 1 > surprise Percent
27.5229
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-1.39
Earnings History > 2 > eps Estimate
-1.53
Earnings History > 2 > eps Difference
0.14
Earnings History > 2 > surprise Percent
9.1503
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-19
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-2.9
Earnings History > 3 > eps Estimate
-1.95
Earnings History > 3 > eps Difference
-0.95
Earnings History > 3 > surprise Percent
-48.7179
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.07
Earnings History > 4 > eps Estimate
-0.29
Earnings History > 4 > eps Difference
0.36
Earnings History > 4 > surprise Percent
124.1379
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.22
Earnings History > 5 > eps Estimate
-0.39
Earnings History > 5 > eps Difference
0.17
Earnings History > 5 > surprise Percent
43.5897
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-13
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.55
Earnings History > 6 > eps Estimate
-0.9
Earnings History > 6 > eps Difference
0.35
Earnings History > 6 > surprise Percent
38.8889
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-15
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.37
Earnings History > 7 > eps Estimate
-0.87
Earnings History > 7 > eps Difference
-0.5
Earnings History > 7 > surprise Percent
-57.4713
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.87
Earnings History > 8 > eps Estimate
-1.06
Earnings History > 8 > eps Difference
0.19
Earnings History > 8 > surprise Percent
17.9245
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-11
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.98
Earnings History > 9 > eps Estimate
-2.73
Earnings History > 9 > eps Difference
1.75
Earnings History > 9 > surprise Percent
64.1026
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-2.08
Earnings History > 10 > eps Estimate
-5.08
Earnings History > 10 > eps Difference
3
Earnings History > 10 > surprise Percent
59.0551
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-30
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-18.24
Earnings History > 11 > eps Estimate
-28.88
Earnings History > 11 > eps Difference
10.64
Earnings History > 11 > surprise Percent
36.8421
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.74
Earnings History > 12 > eps Estimate
-3.2
Earnings History > 12 > eps Difference
2.46
Earnings History > 12 > surprise Percent
76.875
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-4.8
Earnings History > 13 > eps Estimate
-3.4
Earnings History > 13 > eps Difference
-1.4
Earnings History > 13 > surprise Percent
-41.1765
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.2
Earnings History > 14 > eps Estimate
-3.2
Earnings History > 14 > eps Difference
2
Earnings History > 14 > surprise Percent
62.5
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-9
Earnings History > 15 > eps Estimate
-0.4
Earnings History > 15 > eps Difference
-8.6
Earnings History > 15 > surprise Percent
-2150
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.71
Earnings History > 16 > eps Estimate
-0.71
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-16
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.06
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-07
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0.25
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-15
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.2943
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-09
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0.03
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-07
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0.4
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0514
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-10
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.0552
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-09-30
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
70.6312
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-06-30
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
60.4485
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-03-31
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
111.7708
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2018-12-31
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-68.5202
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-09-30
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-42.2414
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-06-30
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-47.0442
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-03-31
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-16.5305
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company's lead product candidate is PF614, a TAAP oxycodone prodrug candidate for the treatment of severe or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection. It is also developing PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for attention deficit hyperactivity disorder; and PF9001 to treat Opioid use disorder.Ensysce Biosciences, Inc. was founded in 2003 and is based in La Jolla, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ANew Brazil patent backs Ensysce bid for safer opioid pain drugs Stock Titan
Read more →Why analysts upgrade Crocs Inc. stock - CPI Data & Safe Swing Trade Setup Alerts bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$19.225
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 6.55% of the total shares of Ensysce Biosciences Inc
1.
Perceptive Advisors LLC(2.9196%)
since
2025/06/30
2.
Adage Capital Partners Gp LLC(2.5168%)
since
2025/06/30
3.
Geode Capital Management, LLC(0.3423%)
since
2025/06/30
4.
Fidelity Extended Market Index(0.2752%)
since
2025/07/31
5.
FNY Investment Advisers, LLC(0.1011%)
since
2025/06/30
6.
Vanguard Institutional Extnd Mkt Idx Tr(0.08%)
since
2025/07/31
7.
SBI Securities Co Ltd(0.0787%)
since
2025/06/30
8.
Spartan Extended Market Index Pool F(0.0688%)
since
2025/07/31
9.
Fidelity Series Total Market Index(0.0559%)
since
2025/07/31
10.
Tower Research Capital LLC(0.0461%)
since
2025/06/30
11.
Spartan Total Market Index Pool G(0.0341%)
since
2025/07/31
12.
Morgan Stanley - Brokerage Accounts(0.0127%)
since
2025/06/30
13.
UBS Group AG(0.0119%)
since
2025/06/30
14.
BlackRock Inc(0.0022%)
since
2025/06/30
15.
Bank of America Corp(0.0006%)
since
2025/06/30
16.
NT Ext Equity Mkt Idx Fd - NL(0.0004%)
since
2025/06/30
17.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0003%)
since
2025/06/30
18.
NT Ext Equity Mkt Idx Fd - L(0.0001%)
since
2025/06/30
19.
Murchinson Ltd.(0%)
since
2025/06/30
20.
Sabby Management LLC(0%)
since
2025/06/30
21.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0%)
since
2025/06/30
22.
State St US Extended Mkt Indx NL Cl C(0%)
since
2025/08/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.29
EPS Estimate
-0.93
EPS Difference
-0.36
Surprise Percent
-38.7097%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.